Stay updated on Zenocutuzumab Clinical Trial in NRG1 Fusion
Sign up to get notified when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.

Latest updates to the Zenocutuzumab Clinical Trial in NRG1 Fusion page
- Check2 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0. This appears to be a minor version update with no changes to the study content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated to v3.5.0 (replacing the previous v3.4.3).SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded: Revision: v3.4.2. Deleted: the government funding lapse notice and Revision: v3.4.1. The study details and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check74 days agoChange DetectedA global notice about government funding lapse and NIH Clinical Center operating status was added, directing users to official sources for updates. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check81 days agoChange DetectedThe update adds a glossary display, updates QC-related metadata (Last Update Submitted that Met QC Criteria) and the revision version (v3.4.0), and removes an older QC entry and the No FEAR Act data label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Zenocutuzumab Clinical Trial in NRG1 Fusion
Enter your email address, and we'll notify you when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.